|

AUTO1 Clinical Trials

1 actively recruiting trial across 1 location

Also known as: Obecabtagene autoleucel (obe-cel)

Pipeline

Phase 1: 1

Top Sponsors

  • Autolus Limited1

Indications

  • Relapsed or Refractory B Cell Acute Lymphoblastic Leukemia1
  • Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma1
  • Cancer1

Philadelphia, Pennsylvania1 trial

A Study of CD19 Targeted CAR T Cell Therapy in Pediatric Patients With Relapsed or Refractory B Cell Acute Lymphoblastic Leukemia (B ALL) and Aggressive Mature B-cell Non-Hodgkin Lymphoma (B NHL)

Children's Hospital of Philadelphia

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.